Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × enzalutamide × 90 days × Clear all

Phase

Status

Sponsor Class

INDUSTRY 39 OTHER 24 NIH 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1 Adenocarcinoma 1

Interventions

Specimen Handling 35 Magnetic Resonance Spectroscopy 30 Cyclophosphamide 21 Cisplatin 19 Radiation 18 Vincristine 17 Carboplatin 16 Radiotherapy 13 Etoposide 13 Biopsy 12 Dexamethasone 11 Irinotecan 10 Doxorubicin 10 Radiotherapy, Intensity-Modulated 9 Platinum 9 Methotrexate 9 Leucovorin 9 Gemcitabine 9 1,2-diaminocyclohexaneplatinum II citrate 9 fludarabine 8 Stem Cell Transplantation 8 Observation 8 Fluorouracil 8 Cytarabine 8 merphos 7 dehydroftorafur 7 daratumumab 7 Spinal Puncture 7 durvalumab 6 X-Rays 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06592924 2026-01-14

TRIPLE-SWITCH

Canadian Cancer Trials Group

Phase 3 Recruiting

Adenocarcinoma, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡